When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OVID - Ovid nabs Rare Pediatric Disease Designation for OV101 for Angelman Syndrome
Ovid Therapeutics Inc.
The FDA has granted Rare Pediatric Disease Designation to Ovid Therapeutics' (NASDAQ:OVID) OV101 (gaboxadol) for the treatment of Angelman syndrome, a rare genetic condition characterized by a variety of signs and symptoms, including delayed development, intellectual disability, speech impairment, problems with movement and balance, seizures, sleep disorders and anxiety.
More news on: Ovid Therapeutics Inc., Healthcare stocks news,